Skip to Main Content
Contribute Try STAT+ Today

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is mildly ambitious. We plan to putter around the castle, check in on the Pharmalot ancestors, and spend some mindless time in front of the telly. And what about you? This may be a good time to enjoy the great outdoors. You could boost the economy by placing some holiday gift orders or celebrate the virtues of free and fair elections. Or you could look in on someone feeling a bit isolated these days. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

U.S. infectious disease expert Anthony Fauci said vaccine developers should push to make billions of their Covid-19 vaccines to ensure access to all parts of the world, instead of focusing on the rich countries, Reuters says. Experts have raised doubts about access to the vaccine from Pfizer (PFE) and BioNTech (BNTX), especially in developing countries, because it needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below, posing infrastructure challenges.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.